| Jun 25 | Jun 24 | Jun 23 | Jun 22 | Jun 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 70.69K | $ 84.48K | $ 119.34K | $ 94.05K | $ 160.83K |
| Gross Profit | $ 46.79K | $ 56.59K | $ 83.40K | $ 63.51K | $ 115.52K |
| Operating Income | $ -363.22K | $ -378.91K | $ -444.65K | $ -403.55K | $ -370.83K |
| EBITDA | $ -363.22K | $ -378.91K | $ -441.25K | $ -166.99K | $ -370.83K |
| Net Income | $ -413.61K | $ -418.03K | $ -472.74K | $ -420.49K | $ -372.03K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.21K | $ 29.80K | $ 54.83K | $ 271.68K | $ 18.91K |
| Total Assets | $ 37.68K | $ 54.75K | $ 80.85K | $ 296.67K | $ 71.47K |
| Total Debt | $ 713.39K | $ 670.00K | $ 570.00K | $ 520.00K | $ 139.50K |
| Net Debt | $ 712.18K | $ 640.20K | $ 515.17K | $ 248.32K | $ 120.59K |
| Total Liabilities | $ 2.85M | $ 2.45M | $ 2.10M | $ 1.85M | $ 1.20M |
| Stockholders' Equity | $ -2.81M | $ -2.40M | $ -2.02M | $ -1.55M | $ -1.13M |
| Cash Flow | |||||
| Free Cash Flow | $ -71.98K | $ -174.83K | $ -266.85K | $ -127.73K | $ -57.95K |
| Operating Cash Flow | $ -71.98K | $ -174.83K | $ -266.85K | $ -127.73K | $ -57.95K |
| Investing Cash Flow | $ 0.00 | $ -191.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 43.39K | $ 150.00K | $ 50.00K | $ 380.50K | $ 0.00 |
CYduct Diagnostics Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.